Skip to main content
. 2021 Sep 16;10(18):e021312. doi: 10.1161/JAHA.121.021312

Figure 7. Summary of physiological and kidney histological and transcriptomic responses to development of, and recovery from, ADHF.

Figure 7

ACADVL indicates acyl‐CoA dehydrogenase very long chain; ACTG2, actin gamma 2, smooth muscle; ADHF, acute decompensated heart failure; ADIPOQ, adiponectin, C1Q, and collagen domain containing; ANGPTL4, angiopoietin like 4; BGN, biglycan CA2, carbonic anhydrase 2; CAPN1, calpain 1; CFI, complement factor I; CNGA3, cyclic nucleotide gated channel subunit alpha 3; DES, desmin; eNOS, endothelial nitric oxide synthase; FLT4, Fms related tyrosine kinase 4; FSTL3, follistatin like 3; GLTP, glycolipid transfer protein; HPCA, hippocalcin; HSP90AA1, heat shock protein 90 alpha family class A member 1; HSP90B1, heat shock protein 90 beta family member 1; IGFBP3, insulin like growth factor binding protein 3; IL1β, interleukin 1β; KLF7, Kruppel like factor 7; LARP1B, La ribonucleoprotein domain family member 1B; MUC20, mucin 20; NGFR, nerve growth factor receptor; OIT3, oncoprotein induced transcript 3; PCOLCE2, procollagen C‐endopeptidase enhancer 2; PDE5A, phosphodiesterase 5A; PDGF, platelet‐derived growth factor; PDGFRB, platelet derived growth factor receptor beta; PLEKHA8, pleckstrin homology domain containing A8; PPAR, peroxisome proliferator‐activated receptor; REN, renin; SIPA1L1, signal induced proliferation associated 1 like 1; SLC5A1, solute carrier family 5 member 1; SLC52A3, solute carrier family 52 member 3; STAT3, signal transducer and activator of transcription 3; and TXNDC16, thioredoxin domain containing 16.